Product Liability

According to a recent Food and Drug Administration (FDA) press release, Watson Pharmaceuticals, Inc. has announced a voluntary recall of one lot of Propafenone HCL 225 mg tablets, an anti-arrhythmia drug. The tablets are being voluntarily recalled because some tablets may contain higher levels of the drug than is specified on the product labeling. This is a serious issue. Changes in the dosage of Propafenone may affect some patients more than others. The FDA press release mentions irregular h

  • Free Case
    Evaluation

We use cookies to improve your experience on our site and to show you personalized advertising. You can learn more about how we use cookies and how you can opt-out. We do not sell your information.

Accept Decline